Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/263.35
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,3-diazines (e.g., pyrimidines, etc.) > Polycyclo ring system having 1,3-diazine as one of the cyclos > Bicyclo ring system having the 1,3-diazine as one of the cyclos > Exactly four ring nitrogens in the bicyclo ring system > Purine (including hydrogenated) > Chalcogen bonded directly to a ring carbon of the purine ring system > Chalcogen bonded directly to the 2-and 6- positions of the purine ring system (e.g., theophylline, etc.) > Nitrogen attached indirectly to the purine ring system by acyclic nonionic bonding
Description: Subject matter wherein nitrogen is indirectly attached to the purine ring system by acyclic nonionic bonding.










Patents under this class:
1 2

Patent Number Title Of Patent Date Issued
8541423 Methods and compositions for treating pain Sep. 24, 2013
8394808 HM74 receptor agonists:xanthine derivatives, corresponding pharmaceutical compositions, treatment methods and processes Mar. 12, 2013
8389529 Methods and compositions for treating asthma Mar. 5, 2013
8178542 Methods and compositions for treating pain May. 15, 2012
8044061 8-alkynylxanthines and derivatives Oct. 25, 2011
7875603 Specific inhibitors for vascular endothelial growth factor receptors Jan. 25, 2011
7704530 Antimicrobially treated material and methods of preventing coloring thereof Apr. 27, 2010
7671061 Methods and compositions for treating pain Mar. 2, 2010
7589075 Use of an adenosine A3 receptor agonist for inhibition of viral replication Sep. 15, 2009
7579354 Adenosine receptor antagonists and methods of making and using the same Aug. 25, 2009
7560450 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions Jul. 14, 2009
7495004 Purine derivatives as liver X receptor agonists Feb. 24, 2009
7495002 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions Feb. 24, 2009
7495003 8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions Feb. 24, 2009
7482337 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions Jan. 27, 2009
7423041 A1 adenosine receptor antagonists Sep. 9, 2008
7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions Aug. 5, 2008
7312223 Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction Dec. 25, 2007
7247639 A1 adenosine receptor antagonists Jul. 24, 2007
7202252 A.sub.1 adenosine receptor antagonists Apr. 10, 2007
7098217 3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands Aug. 29, 2006
7053096 Compounds having selective hydrolytic potentials May. 30, 2006
6878715 Therapeutic compounds for inhibiting interleukin-12 signals and method for using same Apr. 12, 2005
6869974 Pharmaceutical compounds Mar. 22, 2005
6780865 Compounds having selective hydrolytic potentials Aug. 24, 2004
6734187 Purine derivatives and medicaments comprising the same as active ingredient May. 11, 2004
6649600 Adenosine receptor antagonists and methods of making and using the same Nov. 18, 2003
6638938 Method for preventing tissue injury from hypoxia Oct. 28, 2003
6608069 Phenyl xanthine derivatives Aug. 19, 2003
6605600 Adenosine receptor antagonists and methods of making and using the same Aug. 12, 2003
6558660 Method for regulating IL-10 with IL-9, and applications thereof May. 6, 2003
6489332 A1 adenosine receptor antagonists Dec. 3, 2002
6423719 Method for treating benign prostate hyperplasia Jul. 23, 2002
6350752 Carbon monoxide dependent guanylyl cyclase modifiers and methods of use Feb. 26, 2002
6319894 Complexes and combinations of fetuin with therapeutic agents Nov. 20, 2001
6313131 Method of kidney treatment Nov. 6, 2001
6294541 Purine derivatives having phosphodiesterase IV inhibition activity Sep. 25, 2001
6187780 Assymetrically substituted xanthine derivatives having adenosine A1 antagonistic activity Feb. 13, 2001
6103730 Amine substituted compounds Aug. 15, 2000
6100271 Therapeutic compounds containing xanthinyl Aug. 8, 2000
6043250 Methods for using therapeutic compounds containing xanthinyl Mar. 28, 2000
6025361 Trisubstituted thioxanthines Feb. 15, 2000
5965555 Xanthine compounds having terminally animated alkynol side chains Oct. 12, 1999
5958933 Neurologically active compounds and compounds with multiple activities Sep. 28, 1999
5929081 Method for treating diseases mediated by cellular proliferation in response to PDGF, EGF, FGF and VEGF Jul. 27, 1999
5889011 Substituted amino alkyl compounds Mar. 30, 1999
5861405 S-substituted 1,3,7-trialkyl-xanthine derivatives Jan. 19, 1999
5861396 Purin-6-one derivatives Jan. 19, 1999
5859018 Method for treating diseases mediated by cellular proliferation in response to PDGF, EGF, FGF, and VEGF Jan. 12, 1999
5817662 Substituted amino alkyl compounds Oct. 6, 1998

1 2










 
 
  Recently Added Patents
Fluid conduit with PTC fabric heating
Web development environment that enables a developer to interact with run-time output presentation of a page
Recording apparatus, recording method, reproducing apparatus, reproducing method, program, and recording/producing apparatus
Creation and use of test cases for automated testing of media-based applications
Heteroleptic iridium complexes as dopants
Device and method for controlling brightness of organic light emitting diode display
Viruses lacking epithelial cell receptor entry
  Randomly Featured Patents
On-vehicle gateway device, method for controlling an on-vehicle gateway device, connection device and connection control method
Stabilized scintillation detector for radiation spectroscopy and method
Field effect transistor and fabrication method
Photoconductive devices containing novel benzyl fluorinated squaraine compositions
Completely aromatic polyesters and their preparation
Tunable fiber optic parametric oscillator
Word line decoder circuit
Arm rest assembly
Two-phase-clocked shift register is bipolar technology
Process for forming a negative resist using high energy beam